Furthermore, other anti-HIV CARs demonstrated that swapping CD4-CAR transmembrane domain (TM) for CD8α TM domain decreased CAR homology to the HIV cellular receptor and reduced the susceptibility of CD4- expressing CAR T cell to HIV infection [41]. This evidence concerns the gene CD4 and HIV infectious disease.